Glycobiology, 2002, Vol. 12, No. 3 191-197
© 2002 Oxford University Press
Functional analysis of the carbohydrate recognition domains and a linker peptide of galectin-9 as to eosinophil chemoattractant activity
2Department of Endocrinology, Kagawa Medical University, Kagawa 761-0793, Japan; 3Plastic and Reconstructive Surgery, Kagawa Medical University, Kagawa 761-0793, Japan; 4Galpharma Co., Ltd., Kagawa 761-0703, Japan; 5Immunology and Immunopathology, Kagawa Medical University, Kagawa 761-0793, Japan; 6Department of Biological Chemistry, Faculty of Pharmaceutical Sciences, Teikyo University, Kanagawa 199-01, Japan; and 7Department of Plastic and Reconstructive Surgery, Tokyo Medical and Dental University, Tokyo 113-8510, Japan
Human galectin-9 is a ß-galactoside-binding protein consisting of two carbohydrate recognition domains (CRDs) and a linker peptide. We have shown that galectin-9 represents a novel class of eosinophil chemoattractants (ECAs) produced by activated T cells. A previous study demonstrated that the carbohydrate binding activity of galectin-9 is indispensable for eosinophil chemoattraction and that the N- and C-terminal CRDs exhibit comparable ECA activity, which is substantially lower than that of full-length galectin-9. In this study, we investigated the roles of the two CRDs in ECA activity in conjunction with the sugar-binding properties of the CRDs. In addition, to address the significance of the linker peptide structure, we compare the three isoforms of galectin-9, which only differ in the linker peptide region, in terms of ECA activity. Recombinant proteins consisting of two N-terminal CRDs (galectin-9NN), two C-terminal CRDs (galectin-9CC), and three isoforms of galectin-9 (galectin-9S, -9M, and -9L) were generated. All the recombinant proteins had hemagglutination activity comparable to that of the predominant wild-type galectin-9 (galectin-9M). Galectin-9NN and galectin-9CC induced eosinophil chemotaxis in a manner indistinguishable from the case of galectin-9M. Although the isoform of galectin-9 with the longest linker peptide, galectin-9L, exhibited limited solubility, the three isoforms showed comparable ECA activity over the concentration range tested. The interactions between N- and C-terminal CRDs and glycoprotein glycans and glycolipid glycans were examined using frontal affinity chromatography. Both CRDs exhibited high affinity for branched complex type sugar chain, especially for tri- and tetraantennary N-linked glycans with N-acetyllactosamine units, and the oligosaccharides inhibited the ECA activity at low concentrations. These results suggest that the N- and C-terminal CRDs of galectin-9 interact with the same or a closely related ligand on the eosinophil membrane when acting as an ECA and that ECA activity does not depend on a specific structure of the linker peptide.
1 To whom correspondence should be addressed at Kagawa Medical University
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Nagae, N. Nishi, T. Murata, T. Usui, T. Nakamura, S. Wakatsuki, and R. Kato Structural analysis of the recognition mechanism of poly-N-acetyllactosamine by the human galectin-9 N-terminal carbohydrate recognition domain Glycobiology, February 1, 2009; 19(2): 112 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Stowell, C. M. Arthur, K. A. Slanina, J. R. Horton, D. F. Smith, and R. D. Cummings Dimeric Galectin-8 Induces Phosphatidylserine Exposure in Leukocytes through Polylactosamine Recognition by the C-terminal Domain J. Biol. Chem., July 18, 2008; 283(29): 20547 - 20559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bi, L. A. Earl, L. Jacobs, and L. G. Baum Structural Features of Galectin-9 and Galectin-1 That Determine Distinct T Cell Death Pathways J. Biol. Chem., May 2, 2008; 283(18): 12248 - 12258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Miyanishi, N. Nishi, H. Abe, Y. Kashio, R. Shinonaga, S.-i. Nakakita, W. Sumiyoshi, A. Yamauchi, T. Nakamura, M. Hirashima, et al. Carbohydrate-recognition domains of galectin-9 are involved in intermolecular interaction with galectin-9 itself and other members of the galectin family Glycobiology, April 1, 2007; 17(4): 423 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-H. Lu, R. Nakagawa, Y. Kashio, A. Ito, H. Shoji, N. Nishi, M. Hirashima, A. Yamauchi, and T. Nakamura Characterization of Galectin-9-Induced Death of Jurkat T Cells J. Biochem., February 1, 2007; 141(2): 157 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nagae, N. Nishi, T. Murata, T. Usui, T. Nakamura, S. Wakatsuki, and R. Kato Crystal Structure of the Galectin-9 N-terminal Carbohydrate Recognition Domain from Mus musculus Reveals the Basic Mechanism of Carbohydrate Recognition J. Biol. Chem., November 24, 2006; 281(47): 35884 - 35893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nishi, A. Itoh, H. Shoji, H. Miyanaka, and T. Nakamura Galectin-8 and galectin-9 are novel substrates for thrombin Glycobiology, November 1, 2006; 16(11): 15C - 20C. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Levy, S. Auslender, M. Eisenstein, R. R. Vidavski, D. Ronen, A. D. Bershadsky, and Y. Zick It depends on the hinge: a structure-functional analysis of galectin-8, a tandem-repeat type lectin Glycobiology, June 1, 2006; 16(6): 463 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Popovici, M. S. Krause, A. Germeyer, T. Strowitzki, and M. von Wolff Galectin-9: A New Endometrial Epithelial Marker for the Mid- and Late-Secretory and Decidual Phases in Humans J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6170 - 6176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nishi, H. Shoji, M. Seki, A. Itoh, H. Miyanaka, K. Yuube, M. Hirashima, and T. Nakamura Galectin-8 modulates neutrophil function via interaction with integrin {alpha}M Glycobiology, November 1, 2003; 13(11): 755 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Shoji, N. Nishi, M. Hirashima, and T. Nakamura Characterization of the Xenopus Galectin Family. THREE STRUCTURALLY DIFFERENT TYPES AS IN MAMMALS AND REGULATED EXPRESSION DURING EMBRYOGENESIS J. Biol. Chem., March 28, 2003; 278(14): 12285 - 12293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Asakura, Y. Kashio, K. Nakamura, M. Seki, S. Dai, Y. Shirato, M. J. Abedin, N. Yoshida, N. Nishi, T. Imaizumi, et al. Selective Eosinophil Adhesion to Fibroblast Via IFN-{gamma}-Induced Galectin-9 J. Immunol., November 15, 2002; 169(10): 5912 - 5918. [Abstract] [Full Text] [PDF]
|
|